Review




Structured Review

Jenapharm GmbH Co KG dexamethasone tablets
Effect of prenatal <t>dexamethasone</t> on offspring body weight. Graph shows body weight at different ages in offspring of mothers that received vehicle (Control), or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. * P < 0.05 compared with control animals.
Dexamethasone Tablets, supplied by Jenapharm GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/dexamethasone+dexa/pmc02780883-55-0-7
Average 90 stars, based on 1 article reviews
dexamethasone tablets - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Prenatal Programming of Metabolic Syndrome in the Common Marmoset Is Associated With Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1"

Article Title: Prenatal Programming of Metabolic Syndrome in the Common Marmoset Is Associated With Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1

Journal: Diabetes

doi: 10.2337/db09-0873

Effect of prenatal dexamethasone on offspring body weight. Graph shows body weight at different ages in offspring of mothers that received vehicle (Control), or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. * P < 0.05 compared with control animals.
Figure Legend Snippet: Effect of prenatal dexamethasone on offspring body weight. Graph shows body weight at different ages in offspring of mothers that received vehicle (Control), or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. * P < 0.05 compared with control animals.

Techniques Used: Control

Effect of prenatal dexamethasone on 11β-HSD1 expression in the liver. Hepatic 11β-HSD1 mRNA expression was measured by real-time PCR in 4-month-old ( A ) and 24-month-old ( B ) offspring of mothers that received vehicle (Control) or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. 11β-HSD1 enzyme activity was assessed in 24-month-old livers ( C ). Results represent mRNA expression relative to control animals. * P < 0.05 compared with control animals.
Figure Legend Snippet: Effect of prenatal dexamethasone on 11β-HSD1 expression in the liver. Hepatic 11β-HSD1 mRNA expression was measured by real-time PCR in 4-month-old ( A ) and 24-month-old ( B ) offspring of mothers that received vehicle (Control) or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. 11β-HSD1 enzyme activity was assessed in 24-month-old livers ( C ). Results represent mRNA expression relative to control animals. * P < 0.05 compared with control animals.

Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Control, Activity Assay

11β-HSD1 expression in adipose tissue and pancreas. 11β-HSD1 mRNA expression was measured in subcutaneous fat ( A ), peritoneal fat ( B ) and pancreas ( C ) of in 24-month-old offspring of mothers that received vehicle (Control), or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. Results represent mRNA expression relative to control animals. * P < 0.05.
Figure Legend Snippet: 11β-HSD1 expression in adipose tissue and pancreas. 11β-HSD1 mRNA expression was measured in subcutaneous fat ( A ), peritoneal fat ( B ) and pancreas ( C ) of in 24-month-old offspring of mothers that received vehicle (Control), or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. Results represent mRNA expression relative to control animals. * P < 0.05.

Techniques Used: Expressing, Control

Effect of prenatal dexamethasone on PEPCK expression in the liver. Hepatic PEPCK mRNA ( A ) and activity ( B ) were measured in 24-month-old offspring of mothers that received vehicle (Control) or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. Results represent mRNA expression or enzyme activity relative to control animals. * P < 0.05 compared with control animals.
Figure Legend Snippet: Effect of prenatal dexamethasone on PEPCK expression in the liver. Hepatic PEPCK mRNA ( A ) and activity ( B ) were measured in 24-month-old offspring of mothers that received vehicle (Control) or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. Results represent mRNA expression or enzyme activity relative to control animals. * P < 0.05 compared with control animals.

Techniques Used: Expressing, Activity Assay, Control

Effect of dexamethasone on glucocorticoid receptor expression. Tissue glucocorticoid receptor mRNA was measured in liver ( A ), subcutaneous fat ( B ), peritoneal fat ( C ), and pancreas ( D ) by real-time PCR in 24-month-old offspring of mothers that received vehicle (Control) or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. Results are expressed as mRNA expression relative to control animals.
Figure Legend Snippet: Effect of dexamethasone on glucocorticoid receptor expression. Tissue glucocorticoid receptor mRNA was measured in liver ( A ), subcutaneous fat ( B ), peritoneal fat ( C ), and pancreas ( D ) by real-time PCR in 24-month-old offspring of mothers that received vehicle (Control) or dexamethasone during early (Early-DEX) or late (Late-DEX) pregnancy. Results are expressed as mRNA expression relative to control animals.

Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Control

Related Articles

other:

Article Title: IRF4 deficiency vulnerates B progeny for leukemogenesis via Jak3 mutations resembling Ph-like B-ALL in humans
Article Snippet: When blast cells in pB reached 25 (mean 50) %, therapy was initiated with oral Dexamethasone (Jenapharm) at 6 mg/L supplied ad libitum in the drinking water for seven days.

Article Title: Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.
Article Snippet: The aim of this prospective clinical trial was to investigate the efficacy and toxicity of a short-term, maintenance-free chemotherapy protocol in feline lymphoma.. Twenty-six cats with confirmed diagnosis of high-/intermediate-grade lymphoma were treated with a 12-week protocol consisting of cyclic administration of L-asparaginase, vincristine, cyclophosphamide, doxorubicin and prednisolone.. Complete (CR) and partial remission (PR) rates were 46 and 27%, respectively.

Article Title: High dose ibuprofen as a monotherapy on an around-the-clock basis fails to control pain in children undergoing tonsil surgery: a prospective observational cohort study.
Article Snippet: Purpose The optimal pain management concept in children after tonsil surgery is controversial.. Ibuprofen on an “aroundthe-clock” basis has been suggested to control postoperative pain sufficiently.. Therefore, we established a standard scheme with weight-adapted recommended maximum ibuprofen dose.


Article Title: 23- vs 20-gauge pars plana vitrectomy in combination with bimanual microincisional cataract surgery (b-MICS) for the treatment of macular hole and cataract as a one-step procedure
Article Snippet: Each patient received a peribulbar administration of 75 mg cefuroxim (Hexal AG, Holzkirchen, Germany) and 4 mg dexamethason (Jenapharm, Jena, Germany).

Article Title: IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.
Article Snippet: When blast cells in pB reached 25 (mean 50)%, therapy was initiated with oral Dexamethasone (Jenapharm) at 6 mg/L supplied ad libitum in the drinking water for seven days.

Article Title: High uptake of 68 Ga-PSMA and 18 F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes.
Article Snippet: In order to evaluate the influence of BBB permeability on tracer uptake, four rats with U87 gliomas received glucocorticoid treatment with dexamethasone (Jenapharm®, Mibe GmbH).

Article Title: Aberrant hippocampal Ca2+ micro-waves following synapsin-dependent adeno-associated viral expression of Ca2+ indicators
Article Snippet: Furthermore, dexamethasone (Dexa, Jenapharm; 0.1 mg/20 g b.w.



Similar Products

94
MedChemExpress dexa hioc group
<t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
Dexa Hioc Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/HIOC/pmc13273678-279-15-23
Average 94 stars, based on 1 article reviews
dexa hioc group - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Hologic Inc whole body dexa scans
<t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
Whole Body Dexa Scans, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/body+dxa+scans+whole/pmc09530065-50-12-18
Average 86 stars, based on 1 article reviews
whole body dexa scans - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Hologic Inc dexa
<t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
Dexa, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/dxa/pm42319724-54-4-6
Average 86 stars, based on 1 article reviews
dexa - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Dopharma Inc dexa ject dexamethasone injection dopharma 2 animal
<t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
Dexa Ject Dexamethasone Injection Dopharma 2 Animal, supplied by Dopharma Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/2+animal+dexa+dexamethasone+dopharma+injection+ject/us12653891-700-0-3
Average 86 stars, based on 1 article reviews
dexa ject dexamethasone injection dopharma 2 animal - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Tokyo Chemical Industry dexamethasone 21 phosphate disodium salt hydrate dexa
<t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
Dexamethasone 21 Phosphate Disodium Salt Hydrate Dexa, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/disodium+etidronate+hydrate/10__1002_slash_adfm__76329-234-0-10
Average 86 stars, based on 1 article reviews
dexamethasone 21 phosphate disodium salt hydrate dexa - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Matsunami Glass dexa scans
<t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
Dexa Scans, supplied by Matsunami Glass, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/dexa+scans/pmc13195716-100-24-44
Average 86 stars, based on 1 article reviews
dexa scans - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
KUB Technologies Inc 3d dual energy x ray absorptiometry dexa instrument
<t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
3d Dual Energy X Ray Absorptiometry Dexa Instrument, supplied by KUB Technologies Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/Parameter+3D+Tomosynthesis/pmc13458708-266-8-15
Average 94 stars, based on 1 article reviews
3d dual energy x ray absorptiometry dexa instrument - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Hologic Inc dexa scans
<t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
Dexa Scans, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa/dexa/pmc13175334-123-1-5
Average 86 stars, based on 1 article reviews
dexa scans - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


DEXA exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.

Journal: The Journal of Biological Chemistry

Article Title: Stress-induced glucocorticoid signaling impairs enteric neurotrophin BDNF–TrkB pathway and drives gastrointestinal dysmotility

doi: 10.1016/j.jbc.2026.113095

Figure Lengend Snippet: DEXA exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.

Article Snippet: Mice were first housed in individual cages and then those in the HIOC alone and DEXA + HIOC group were treated with HIOC (MedChemExpress, Cat. No. HY-101446; 50 mg/kg body weight in 10% DMSO, intraperitoneal route), while those in DEXA group were treated with equal volume of 10% DMSO in saline as a control for HIOC (intraperitoneal route).

Techniques: Expressing, Staining, Control, Saline, Two Tailed Test, Cell Culture, Enzyme-linked Immunosorbent Assay, Derivative Assay

HIOC ameliorates delayed whole gut motility in mice with DEXA -induced dysmotility. DEXA-treated adult male mice that were pre-treated with HIOC - the synthetic and specific agonist of TrkB - showed significant reduction in their WGTT of orally gavaged carmine-red dye, and hence improved whole gut motility, when compared to age- and sex-matched mice that were dosed only with DEXA (n = 9/cohort; mean ± S.E. of WGTT (in min): DEXA only : 228.3 ± 7.12; DEXA + HIOC : 150.0 ± 21.94). By contrast, HIOC dosing of mice in the absence of DEXA treatment does not cause any change in the WGTT of mice (n = 5/cohort; mean ± S.E. of WGTT ( in min ): Vehicle control ( No DEXA + No HIOC) : 151.0 ± 15.44; HIOC only : 154.0 ± 13.91. Statistically significant main effects found for DEXA treatment, F(1, 24) = 4.419, p = 0.0462; for HIOC treatment, F(1, 24) = 4.663, p = 0.0410; and for interaction between DEXA and HIOC treatments, F(1, 24) = 5.436, p = 0.0285 (Two-Way ANOVA). Sidak’s multiple comparisons test reveals statistically significant differences between DEXA+/HIOC- and DEXA+/HIOC+ mice; between DEXA+/HIOC- and DEXA-/HIOC+ mice; and between DEXA+/HIOC- and DEXA-/HIOC+ mice. Differences between all other comparisons were found to be not statistically significant (∗p adj < 0.05, ∗∗p adj < 0.01, ns = p adj > 0.05). WGTT, whole gut transit time; DEXA, dexamethasone.

Journal: The Journal of Biological Chemistry

Article Title: Stress-induced glucocorticoid signaling impairs enteric neurotrophin BDNF–TrkB pathway and drives gastrointestinal dysmotility

doi: 10.1016/j.jbc.2026.113095

Figure Lengend Snippet: HIOC ameliorates delayed whole gut motility in mice with DEXA -induced dysmotility. DEXA-treated adult male mice that were pre-treated with HIOC - the synthetic and specific agonist of TrkB - showed significant reduction in their WGTT of orally gavaged carmine-red dye, and hence improved whole gut motility, when compared to age- and sex-matched mice that were dosed only with DEXA (n = 9/cohort; mean ± S.E. of WGTT (in min): DEXA only : 228.3 ± 7.12; DEXA + HIOC : 150.0 ± 21.94). By contrast, HIOC dosing of mice in the absence of DEXA treatment does not cause any change in the WGTT of mice (n = 5/cohort; mean ± S.E. of WGTT ( in min ): Vehicle control ( No DEXA + No HIOC) : 151.0 ± 15.44; HIOC only : 154.0 ± 13.91. Statistically significant main effects found for DEXA treatment, F(1, 24) = 4.419, p = 0.0462; for HIOC treatment, F(1, 24) = 4.663, p = 0.0410; and for interaction between DEXA and HIOC treatments, F(1, 24) = 5.436, p = 0.0285 (Two-Way ANOVA). Sidak’s multiple comparisons test reveals statistically significant differences between DEXA+/HIOC- and DEXA+/HIOC+ mice; between DEXA+/HIOC- and DEXA-/HIOC+ mice; and between DEXA+/HIOC- and DEXA-/HIOC+ mice. Differences between all other comparisons were found to be not statistically significant (∗p adj < 0.05, ∗∗p adj < 0.01, ns = p adj > 0.05). WGTT, whole gut transit time; DEXA, dexamethasone.

Article Snippet: Mice were first housed in individual cages and then those in the HIOC alone and DEXA + HIOC group were treated with HIOC (MedChemExpress, Cat. No. HY-101446; 50 mg/kg body weight in 10% DMSO, intraperitoneal route), while those in DEXA group were treated with equal volume of 10% DMSO in saline as a control for HIOC (intraperitoneal route).

Techniques: Control